Biallelic alternatives involving ATP13A3 cause dose-dependent childhood-onset lung arterial hypertension classified by simply extreme morbidity as well as death.
Biallelic alternatives involving ATP13A3 cause dose-dependent childhood-onset lung arterial hypertension classified by simply extreme morbidity as well as death.